Serum sICAM-1 (soluble intercellular adhesion molecule-1) and M-CSF (macrophage colony-stimulating growth factor) throughout monitoring of 34 non-serous ovarian cancers

European Journal of Gynaecological Oncology

Volumn 21, Issue 2, 2000, Pages 135-140

  Callet, N ^a   Delaunay, J ^a   Pichon, Marie France ^a  

^a CENTRE RENÉ HUGUENIN   (France)

Author keywords

ICAM 1; M CSF (CSF 1); Ovarian cancer

Indexed keywords

ANTINEOPLASTIC AGENT; BIOLOGICAL MARKER; CA 125 ANTIGEN; COLONY STIMULATING FACTOR 1; GESTAGEN; INTERCELLULAR ADHESION MOLECULE 1;

ADULT; AGED; ARTICLE; BLOOD LEVEL; BLOOD SAMPLING; CANCER STAGING; CLINICAL ARTICLE; CORRELATION FUNCTION; ENZYME LINKED IMMUNOSORBENT ASSAY; FEMALE; HORMONAL THERAPY; HUMAN; OVARY ADENOCARCINOMA; OVARY CANCER;

ADENOCARCINOMA; AGED; CA-125 ANTIGEN; ENZYME-LINKED IMMUNOSORBENT ASSAY; FEMALE; HUMANS; INTERCELLULAR ADHESION MOLECULE-1; MACROPHAGE COLONY-STIMULATING FACTOR; MIDDLE AGED; MONITORING, PHYSIOLOGIC; OVARIAN NEOPLASMS; PROGNOSIS; RETROSPECTIVE STUDIES; ROC CURVE; SAMPLING STUDIES; SENSITIVITY AND SPECIFICITY; TUMOR MARKERS, BIOLOGICAL;

EID: 0034053506     PISSN: 03922936     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (23)

1. Santin A. D., Rose G. S., Hiserodt J. C., Fruehaurf J., Eck L. M., Garcia R. I. et al.: "Effects of cytokines combined with high-dose gamma irradiation on the expression of major histocompatibility complex molecules and intercellular adhesion molecule-1 in human ovarian cancers". Int. J. Cancer, 1996, 65, 688.
2. Takizawa K., Kamijo R., Ito D., Hatori M., Sumitami K., Nagumo M.: "Synergistic induction of ICAM-1 by cisplatin and 5-fluorouracil in a cancer cell line via a NF-κB independent pathway". Br. J. Cancer, 1999, 80, 954.
3. Banks R. E., Gearing A. J. H., Hemingway I. K., Norfolk D. R., Peren T. J., Selby P. J.: "Circulating intercellular adhesion molecule-1 (ICAM-1), E-Selectin and vascular cell adhesion molecule-1 (VCAM-1) in human malignancies". Br. J. Cancer, 1993, 68, 122.
4. Giavazzi R., Nicoletti M. I., Chirivi R. G. S., Hemingway I., Bernasconi S., Allavena P. et al.: "Soluble intercellular adhesion molecule-1 (ICAM-1) is released into the serum and ascites of human ovarian carcinoma patients and in nude mice bearing tumour xenografts". Eur. J. Cancer, 1994, 30A, 1865.
5. Ferdeghini M., Gadducci A., Prontera C., Annichiardo C., Gagetti O., Bianchi M. et al.: "Preoperative serum intercellular adhesion molecule-1 (ICAM-1) and E-selectin (endothelial cell leukocyte adhesion molecule ELAM-1) in patients with epithelial ovarian cancer". Anticancer Res., 1995, 15, 2255.
6. Darai E., Bringuier A. F., Walker-Combouze F., Feldmann G., Madelenat P., Scoazec J. Y.: "Soluble adhesion molecules in serum and cyst from patients with cystic tumours of the ovary". Human Reprod., 1998, 13, 2831.
7. Fixe P., Praloran V.: "M-Csf: haematopoietic growth factor or inflammatory cytokine?". Cytokine, 1998, 10, 32.
8. Kommoss F., Wolfe T., Bauknecht J., Pfisterer M., Kiechle-Schwartz A. et al.: "Co-expression of M-CSF transcripts and protein, FMS (M-CSF receptor) transcripts and protein, and steroid receptor content in adenocarcinomas of the ovary". J. Pathol., 1994, 174, 11.
9. Keshava N., Gubba S., Tekmal R. R.: "Overexpression of macrophage colony-stimulating factor (CSF-1) and its receptor, c-fms, in normal ovarian granulosa cells leads to cell proliferation and tumorigenesis". J. Soc. Gynecol. Investing, 1999, 6, 41.
10. Praloran V., Coupey L., Donnard M., Berrada L., Naud M.F.: "Elevation of serum M-CSF concentrations during pregnancy and ovarian hyperstimulation". Br. J. Haematol., 1994, 86, 675.
11. Kacinski B. M., Bloodgood R. S., Schwartz P. E., Carter D., Stanley E. R.: "Macrophage colony-stimulating factor is produced by human ovarian and endometrial adenocarcinoma-derived cell lines and is present at abnormally high levels in the plasma of ovarian carcinoma patients with acctive disease". Cancer Cells, 1989, 333.
12. Chambers S., Kacinski B. M., Ivins C. M., Carcangiu M. L.: "Overexpression of epithelial macropahge colony-stimulating factor (CSF-1) and CSF-1 receptor: a poor prognostic factor in epithelial ovarian cancer, with a protective effect of stroma CSF-1". Clin. Cancer Res., 1997, 3, 999.
13. Kimura F., Takemura Y., Ohtsuki T., Mizukami H., Takagi S., Yamamoto K. et al.: "Serial changes of the serum macrophage colony-stimulating factor level after cytoreductive chemotherapy". Int. J. Hematol., 1992, 55, 147.
14. Scholl S. M., Bascou C. H., Mosseri V., Olivares R., Magdelenat H., Dorval T. et al.: "Circulating levels of colony-stimulating factor 1 as a prognostic indicator in 82 patients with epithelial ovarian cancer". Br. J. Cancer, 1994, 69, 342.
15. Price F. V., Chambers S. K., Chambers J. T., Carcangiu M. L., Schwartz P. E., Kohorn E. I. et al.: "Colony-stimulating factor-1 in primary ascites of ovarian cancer is a significant predictor of survival". Am. J. Obstet. Gynecol., 1993, 168, 520.
16. Kacinski B. M., Stanley E. R., Carter D., Chambers J. T., Chambers S. K., Kohorn E. I. et al.: "Circulating levels of CSF-1 (M-CSF), a lymphohematopoietic cytokine, may be a useful marker of disease status in patients with malignant ovarian neoplasms". Int. J. Radiation Oncology Biol. Phys., 1989, 17, 159.
17. Xu F. J., Ramakrishnan S., Daly L., Soper J. T., Berchuck A., Clarke-Pearson D. et al.: "Increased serum levels of macrophage colony-stimulating factor in ovarian cancer". Am. J. Obstet. Gynecol., 1991, 165, 1356.
18. Suzuki M., Ohwada M., Sato I., Nagamoto M.: "Serum levels of macrophage colony-stimulating factor as a marker for gynecologic malignancies". Oncology, 1995, 52, 128.
19. Elg S. A., Yu Y., Carson L. F., Adcock L. L., Twiggs L. B., Prem K. A., Ramakrishnan S.: "Serum levels of macrophage colony-stimulating factor in patients with ovarian cancer undergoing second-look laparotomy". Am. J. Obstet. Gynecol., 1992, 166, 134.
20. Gadducci A., Ferdeghini M., Castellani C., Annicchiarico C., Prontera C., Facchini V. et al.: "Serum macrophage colony-stimulating factor (M-CSF) levels in patients with epithelial ovarian cancer". Gynecol. Oncol., 1998, 70, 111.
21. Woolas R. P., Xu F. J., Jacobs I. J., Yu Y. H., Daly L., Berchuck A. et al.: "Elevation of multiple serum markers in patients with stage I ovarian cancer". J. Natl. Cancer Inst., 1993, 85, 1748.
22. Woolas R. P., Conaway M. R., Xu F. J., Jacobs I. J., Yu Y. H., Daly L. et al.: "Combinations of multiple serum markers are superior to individual assays for dicriminating malignant from benign pelvic masses". Gynecol. Oncol., 1995, 59, 111.
23. Rodhe L. E., Hennekens C. H., Ridker P. M.: "Cross-sectional study of soluble intercellular adhesion molecule-1 and cardiovascular risk factors in apparently healthy men". Arterioscler. Thromb. Vasc. Biol., 1999, 19, 1595.